No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
WST240621C480000
- 0.80
- 0.000.00%
15min DelayClose Jun 12 16:00 ET
0.00High0.00Low
0.80Open0.80Pre Close0 Volume2 Open Interest480.00Strike Price0.00Turnover117.92%IV42.07%PremiumJun 21, 2024Expiry Date0.00Intrinsic Value100Multiplier8DDays to Expiry0.80Extrinsic Value100Contract SizeAmericanOptions Type0.0348Delta0.0012Gamma423.03Leverage Ratio-0.2516Theta0.0026Rho14.74Eff Leverage0.0404Vega
Intraday
- 5D
- 1D
News
WARF Appoints Deborah Keller Board Chair
MADISON, Wis., June 11, 2024 /PRNewswire/ -- Deborah Keller, an accomplished life sciences executive with extensive global experience in drug development, has been appointed Chair of the WARF Board o
At US$315, Is It Time To Put West Pharmaceutical Services, Inc. (NYSE:WST) On Your Watch List?
Today we're going to take a look at the well-established West Pharmaceutical Services, Inc. (NYSE:WST). The company's stock received a lot of attention from a substantial price movement on the NYS
Peering Into West Pharmaceutical Servs's Recent Short Interest
West Pharmaceutical Servs's (NYSE:WST) short percent of float has risen 9.04% since its last report. The company recently reported that it has 1.14 million shares sold short, which is 2.05% of all reg
West Pharmaceutical Services, Inc. (NYSE:WST): The Best Dividend Aristocrat Stock According to Analysts
Sell Ideas in Staples and Health Care - Oppenheimer
Express News | West Pharmaceutical Announced Today That It Will Unveil Its New Daikyo Crystal Zenith Nested Vials In Tub At The International Society For Cell And Gene Therapy Annual Meeting Taking Place In Vancouver, Canada
Comments
RECAP
U.S. equity indexes rose after Thursday, with the $Nasdaq Composite Index(.IXIC.US$ lagging the pack, as investors weighed retail sales and jobless claims ahead of more inflation data this week.
The $S&P 500 Index(.SPX.US$ rose 0.58% to 5,029, a new closing high with the $Dow Jones Industrial Average(.DJI.US$ up 0.91% to 38,664. The $Nasdaq Composite Index(.IXIC.US$ was moderately higher at 15,906, af...
U.S. equity indexes rose after Thursday, with the $Nasdaq Composite Index(.IXIC.US$ lagging the pack, as investors weighed retail sales and jobless claims ahead of more inflation data this week.
The $S&P 500 Index(.SPX.US$ rose 0.58% to 5,029, a new closing high with the $Dow Jones Industrial Average(.DJI.US$ up 0.91% to 38,664. The $Nasdaq Composite Index(.IXIC.US$ was moderately higher at 15,906, af...
41
5
Analysts worry about the company's shifting tone and the enduring effect of clients' inventory management on West's finances. Doubts also arise about the company's demand visibility and if current trends suggest a fundamental issue in West's base business.
Jefferies analyst David Windley sees FDA approvals of GLP-1s for obesity treatment as a huge opportunity for the manufacturing supply chain. He also notes high rivalry in the injectable fill/finish market. Windley upgraded West Pharmaceutical to Buy, raising its price target by 66% to $536, citing its global footprint and capacity to meet growing GLP-1s demand.
The market sentiment around West Pharmaceutical Services hasn't changed much over the past five years, with the share price seemingly reacting to the EPS. The recent improvement in TSR could indicate that the business is getting better with time.
1
The 4- and 5-star rated Dividend Aristocrats for 2024 include Abbott Laboratories, AbbVie Inc., Air Products & Chemicals, and others such as Coca-Cola Co., McDonald's Corp., Walmart Inc., and West Pharmaceuticals.
1
Read more
Qulynnitha Bowman : How much money do i need to invest in stocks
102556055 : $Futu Holdings Ltd (FUTU.US)$
Cypher : “$Microsoft(MSFT.US)$'s OpenAi released a short 60-minute video.”
The video is 60 seconds, not minutes. The writing quality on this platform has really been down lately. I’ve caught way too many errors.
bellalita : good news
Malik ritduan : oo